
Rejoyn, a new app being prescribed as a depression treatment, is an emotional face memory task designed to correct abnormal neural circuits.
Dr Charney is the dean of the Icahn School of Medicine at Mount Sinai. He is the author of Neurobiology of Mental Illness, The Physician’s Guide to Depression and Bipolar Disorders, and Molecular Biology for the Clinician. He is a professor of psychiatry, neuroscience, and pharmacology and systems therapeutics at Icahn School of Medicine at Mount Sinai.
Rejoyn, a new app being prescribed as a depression treatment, is an emotional face memory task designed to correct abnormal neural circuits.
Dennis S. Charney, MD, discussed the importance of trying and risking failure when studying new potential treatments, as well as the future of treating depression.
Dennis S. Charney, MD, discussed the discovery of ketamine as a rapid-acting treatment for depression, its journey from skepticism to FDA approval, and its impact on mental health care.
Dennis S. Charney, MD, shared how he encouraged front line health care workers at Mount Sinai during the COVID-19 Pandemic.
Dennis S. Charney, MD, shared how he has fostered success during his tenure as the Dean of the Icahn School of Medicine at Mount Sinai.
Dennis S. Charney, MD, celebrates the 40th anniversary of Psychiatric Times discussing the history of psychiatry and where he hopes the future lies.